Metabolic basis of chronic graft-versus-host disease
$46,318ZIAFY2018CANIH
Division Of Basic Sciences - Nci
Investigators
Linked publications & trials
Abstract
We completed a prospective metabolic pathway utilization screen in the pre-clinical model of cGVHD. This was accomplished through mass spectrometry studies. Having identified several key metabolites perturbed in cGVHD, we employed hyperpolarized metabolites for imaging in the pre-clinical model. We completed RNA sequencing of T cell subsets in the pre-clinical model, which confirmed metabolic perturbations observed in the prospective metabolic screening. We have begun therapeutically targeting the identified pathways in the pre-clinical GVHD model. Metabolic imaging of patients undergoing hematopoietic stem cell transplantation is planned. Testing of metabolic drugs to treat patients with cGVHD is planned.
View original record on NIH RePORTER →